Biosimilars Report
Biosimilars Report features expert review of new developments in biosimilars including regulation and developments in the US and clinician and payer perspectives of first biosimilars approved in the US.
Biosimilars Report Issue 3, Expert Perspective on Biosimilars from Dr. Sanjiv Agarwala
The current issue features expert perspective on biosimilars from Dr. Sanjiv S. Agarwala.
Biosimilars Report Issue 2, Clinician and Payer Perspectives
The second issue highlights the clincian and payer perspectives on the first biosimilar approved in the US, by Dr. Gary H. Lyman and Dr. Edward Pezalla.
Biosimilars Report Issue 1, Regulation and Development
The premier issue highlights the fundamentals of biosimilar regulation and development in the US and recently released materials on biosimilars, Dr. Edward Li.
